SCHEMBL21630079

SCHEMBL21630079

C=CCOC(=O)N[C@H]1[C@@H](OCc2ccccc2)O[C@H](CO)[C@@H](O)[C@@H]1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 1/20 0.45
▸ LGALS8 O00214 1/20 0.44
▸ SYNJ2 O15056 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ABL1 P00519 1/20 0.41
▸ ALPL P05186 1/20 0.41
▸ ALPI P09923 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ ALPG P10696 1/20 0.41
▸ PABPC1 P11940 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ GALK1 P51570 1/20 0.41
▸ CASP7 P55210 1/20 0.41
▸ CASP6 P55212 1/20 0.41
▸ MCL1 Q07820 1/20 0.41
▸ RIN1 Q13671 1/20 0.41
▸ EIF4H Q15056 1/20 0.41
▸ CA1 P00915 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11070746 0.92 LGALS8 (0.46) SLC6A2LGALS8CA1CA2CA9
SCHEMBL8822976 0.92 LGALS8 (0.46) SLC6A2LGALS8CA1CA2CA9
SCHEMBL11302596 0.92 LGALS8 (0.46) SLC6A2LGALS8CA1CA2CA9
SCHEMBL7768969 0.89 LGALS8 (0.51) SLC6A2LGALS8SYNJ2POLBKDM4E
SCHEMBL2307262 0.84 LGALS8 (0.44) SLC6A2LGALS8SYNJ2POLBKDM4E
SCHEMBL16218793 0.84 LGALS8 (0.44) SLC6A2LGALS8SYNJ2POLBKDM4E
SCHEMBL2307255 0.84 LGALS8 (0.44) SLC6A2LGALS8SYNJ2POLBKDM4E
SCHEMBL26103746 0.84 LGALS8 (0.44) SLC6A2LGALS8SYNJ2POLBKDM4E
SCHEMBL15514659 0.84 SLC6A2 (0.49) SLC6A2LGALS8SYNJ2POLBKDM4E
SCHEMBL8652701 0.82 SLC6A2 (0.48) SLC6A2LGALS8SYNJ2POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001912-A1 IL-17A BINDING PEPTIDES AND MEDICAL USES THEREOF DOMPE FARM SPA (IT) 2026-01-01 — — US disclosed
US-12358950-B2 IL-17A binding peptides and medical uses thereof DOMPE' FARMACEUTICI S.P.A. (IT) 2025-07-15 — — US disclosed
CN-112513064-B IL-17A binding peptides and medical uses thereof 东佩制药股份公司 2025-04-22 — — CN disclosed
US-20220112244-A1 IL-17A BINDING PEPTIDES AND MEDICAL USES THEREOF DOMPE' FARMACEUTICI S.P.A. (IT) 2022-04-14 — — US disclosed
US-11236129-B2 IL-17A binding peptides and medical uses thereof DOMPE' FARMACEUTICI S.P.A. (IT) 2022-02-01 — — US disclosed
US-20210300969-A1 IL-17A BINDING PEPTIDES AND MEDICAL USES THEREOF DOMPE' FARMACEUTICI S.P.A. (IT) 2021-09-30 — — US disclosed
EP-3802563-A1 IL-17A BINDING PEPTIDES AND MEDICAL USES THEREOF Dompé farmaceutici S.p.A. (IT) 2021-04-14 — — EP disclosed
CN-112513064-A IL-17A binding peptides and medical uses thereof 东佩制药股份公司 2021-03-16 — — CN disclosed
WO-2020021103-A1 IL-17A BINDING PEPTIDES AND MEDICAL USES THEREOF DOMPE' FARMACEUTICI S.P.A. (IT) 2020-01-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001912-A1 IL-17A BINDING PEPTIDES AND MEDICAL USES THEREOF IL17A, IL36G, IL23R SLC6A2 4601/4885LGALS8 395/4885SYNJ2 2392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback